Dallah Healthcare Company
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Dallah Healthcare Company's yearly results (2022–2025), compared with Healthcare companies in Saudi Arabia. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 12% in 3 years, so each share's slice of the company became smaller. Dividends paid equalled 41% of profit over the same period. Bigger rise in share count than 96% of Healthcare companies in Saudi Arabia.
- Tangible Net Worth Ratio: Of every SAR 100 of net worth, SAR 83 is tangible; the rest is goodwill and other intangibles, often from buying other companies. Less tangible than 86% of Healthcare companies in Saudi Arabia.
- Tangible Assets Ratio: Of every SAR 100 the company owns, SAR 92 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 86% of Healthcare companies in Saudi Arabia.
Where SAR 100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
SAR 136Over the last 3 years, every SAR 100 of reported profit came with SAR 136 of operating cash.
Lower than 54% of Healthcare companies in Saudi Arabia.
Self-Funding Ratio
1.6×Over the last 3 years its own operating cash covered its investment spending (capex) 1.6 times.
Lower than 71% of Healthcare companies in Saudi Arabia.
Cash Locked Ratio
SAR 27For every SAR 100 of sales, SAR 27 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against SAR 26 tied up three years earlier.
Less money tied up than 62% of Healthcare companies in Saudi Arabia.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 75% of Healthcare companies in Saudi Arabia.
Growth Efficiency Ratio
SAR 17Sales grew 63% in 3 years; of every extra SAR 100 of sales, SAR 17 became extra profit.
Higher than 54% of Healthcare companies in Saudi Arabia.
Asset Productivity Ratio
+63% / +86%In 3 years sales changed by +63% while total assets changed by +86%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
0.7×Debt due within a year is covered 0.7 times by its yearly operating cash.
Lower than 71% of Healthcare companies in Saudi Arabia.
Cash Cushion Ratio
−49%Debt, after subtracting cash, equals 49% of its market value (net debt).
Lower than 79% of Healthcare companies in Saudi Arabia.
Tangible Assets Ratio
92%Of every SAR 100 the company owns, SAR 92 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 86% of Healthcare companies in Saudi Arabia.
Tangible Net Worth Ratio
83%Of every SAR 100 of net worth, SAR 83 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 86% of Healthcare companies in Saudi Arabia.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Dallah Healthcare Company owes SAR 0.57 for every SAR 1 it owns. Net profit rose 14% in the year to Dec 2025, and grew 25% a year on average over 3 years.
Compared with Healthcare companies in Saudi Arabia · latest annual results Dec 2025.
P/E ratio
17.2Investors pay SAR 17.2 for every SAR 1 of Dallah Healthcare Company's yearly profit, higher than 71% of Healthcare companies in Saudi Arabia.
P/B ratio
1.83The share price is 1.83 times Dallah Healthcare Company's book value per share, lower than 71% of Healthcare companies in Saudi Arabia.
Market cap
SAR 7.6 BThe total market value of all of Dallah Healthcare Company's shares at today's price (share price × number of shares), larger than 62% of Healthcare companies in Saudi Arabia. PosiCap size class: Meso Cap.
Net worth (book value)
SAR 4.1 BWhat Dallah Healthcare Company would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
SAR 33.88Net worth divided by the number of shares. The share price of SAR 62.00 is 1.8 times this, which is the P/B above.
Return on equity (ROE)
10.3%Dallah Healthcare Company earned 10.3% on its shareholders' money over the last year, lower than 86% of Healthcare companies in Saudi Arabia.
Owes vs Owns
0.57×Dallah Healthcare Company owes SAR 0.57 for every SAR 1 it owns (moderate), lower than 54% of Healthcare companies in Saudi Arabia.
Dividend yield
2.78%Dallah Healthcare Company pays 2.78% of its share price as dividends a year, lower than 62% of dividend-paying Healthcare companies in Saudi Arabia.
Revenue growth
+27%Revenue rose 27% in the year to Dec 2025, and grew 18% a year on average over 3 years.
Profit growth
+14%Net profit rose 14% in the year to Dec 2025, and grew 25% a year on average over 3 years.
Profit margin
13.2%Dallah Healthcare Company keeps SAR 13 of every SAR 100 of revenue as net profit.
Cash quality
1.03×Cash from Dallah Healthcare Company's business was 1.03× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
4.2×Dallah Healthcare Company's operating profit covered its interest costs 4.2 times in the year to Dec 2025.
Cash vs debt
Net debtDallah Healthcare Company had SAR 3.7 B more debt than cash (net debt) at Dec 2025.
Questions
What is Dallah Healthcare Company's P/E ratio?
Investors pay SAR 17.2 for every SAR 1 of Dallah Healthcare Company's yearly profit, higher than 71% of Healthcare companies in Saudi Arabia.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Dallah Healthcare Company: SAR 7.6 B ÷ SAR 4.1 B (30 Jun 2026) = 1.8.
What is Dallah Healthcare Company's return on equity?
Dallah Healthcare Company earned 10.3% on its shareholders' money over the last year, lower than 86% of Healthcare companies in Saudi Arabia.
How much does Dallah Healthcare Company owe compared with what it owns?
Dallah Healthcare Company owes SAR 0.57 for every SAR 1 it owns (moderate), lower than 54% of Healthcare companies in Saudi Arabia.
Does Dallah Healthcare Company pay a dividend?
Yes. Dallah Healthcare Company pays 2.78% of its share price as dividends a year, lower than 62% of dividend-paying Healthcare companies in Saudi Arabia.
Is Dallah Healthcare Company's revenue growing?
Revenue rose 27% in the year to Dec 2025, and grew 18% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.